康臣药业(01681.HK)12月10日耗资527.7万港元回购35.4万股
Core Viewpoint - Kangchen Pharmaceutical (01681.HK) announced a share buyback on December 10, 2023, spending HKD 5.277 million to repurchase 354,000 shares at a price range of HKD 14.75 to 15 per share [1] Group 1 - The company executed a buyback of 354,000 shares [1] - The total expenditure for the buyback was HKD 5.277 million [1] - The buyback price per share ranged from HKD 14.75 to 15 [1]